Shailesh Maingi is Founder/CEO of Kineticos Life Sciences, an award-winning life sciences advisory firm. In 2019, Shailesh launched the Kineticos Disruptor Fund, investing in life science start-ups. In 2020, he started Inceptor Bio, a biotech accelerator hub focused on advanced biological modalities such as gene therapy, cell therapy and gene editing. He cofounded the InVincible Cancer Research Fund in 2019. Shailesh serves on the Board of Directors for numerous biotechs and is Adjunct Faculty at UNC’s Kenan-Flagler School of Business.